Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis

被引:1
|
作者
Giannini, M. [1 ,2 ]
Grignaschi, S. [3 ,4 ,5 ]
Fornaro, M. [1 ]
Caporali, R. [6 ]
Locatelli, F. [3 ,4 ,5 ]
Zanframundo, G. [3 ,4 ,5 ]
Meyer, A. [2 ,5 ,7 ]
Montecucco, C. [3 ,4 ,5 ]
Iannone, F. [1 ]
Paolino, S. [8 ,9 ]
Cavagna, L. [3 ,4 ,5 ]
机构
[1] Univ Bari, Rheumatol Unit DETO, Bari, Italy
[2] Hop Univ Strasbourg, Serv Physiol, Unite Explorat Fonct Musculaires, Strasbourg, France
[3] Univ Pavia, Rheumatol Div, Viale Camillo Golgi 19, I-27100 Pavia, Italy
[4] IRCCS Policlin S Matteo Fdn, Viale Camillo Golgi 19, I-27100 Pavia, Italy
[5] European Reference Network ReCONNET, Milan, Italy
[6] Univ Milan, Hosp G Pini CTO, Rheumatol Div, Milan, Italy
[7] Hop Univ Strasbourg, Serv Rhumatol, Ctr Natl Reference Malad Syst & Autoimmunes Rares, Strasbourg, France
[8] Univ Genoa, Res Lab, Dept Internal Med, Genoa, Italy
[9] Univ Genoa, Acad Div Clin Rheumatol, Dept Internal Med, Genoa, Italy
关键词
thrombocytopenia; idiopathic inflammatory myopathies; myositis specific antibodies; myositis-associated antibodies; INTERSTITIAL LUNG-DISEASE; CELL ACTIVATING FACTOR; THROMBOTIC MICROANGIOPATHY; IMMUNE THROMBOCYTOPENIA; DERMATOMYOSITIS; PATIENT; MORTALITY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Idiopathic inflammatory myopathies (IIMs) are a group of rare connective tissue diseases (CTDs) deeply affecting patients' prognosis. Extra-muscular involvement is not rare and skin, joints and lung are the most common targets. However, also dyserythropoiesis has been described, carrying relevant issues on patients' management and follow-up, as for example, lymphopenia has been associated with an increased risk of rapid progressive interstitial lung disease in anti-MDA5 positive dermatomyositis. Conversely to systemic lupus erythematosus, thrombocytopenia has only been rarely described in IIMs and very few authors have focused on its potential prognostic implications. We describe five cases of thrombocytopenia in IIMs patients positive for myositis specific (MSA) or associated (MAA) autoantibodies. These reports extend the spectrum of haematological features associated to IIMs, focusing also on potential risk factors for thrombocytopenia occurrence.y
引用
收藏
页码:891 / 895
页数:5
相关论文
共 50 条
  • [1] COVID-19 Outcomes in Idiopathic Inflammatory Myopathies A Case Series
    Valle, Ana
    Mahmood, Shereen N.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (03) : 174 - 176
  • [2] ANTI-HMGCR AUTOANTIBODIES IN JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHIES: A CASE SERIES
    Almackenzie, Maha
    Rider, Lisa G.
    Curiel, Rodolfo
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 480 - 480
  • [3] New-onset Idiopathic inflammatory myopathies during pregnancy: a case series
    Chatchaya, Tschappat
    Matthias, Gasser
    Pascal, Seitz
    Martin, Muller
    Britta, Maurer
    Frauke, Forger
    SWISS MEDICAL WEEKLY, 2022, 152 : 21S - 22S
  • [4] Idiopathic inflammatory myopathies
    Vincze, Melinda
    Danko, Katalin
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2012, 26 (01): : 25 - 45
  • [5] Idiopathic inflammatory myopathies
    Andrade-Ortega, Lilia
    Garcia-De La Torre, Ignacio
    REUMATOLOGIA CLINICA, 2009, 5 : 1 - 1
  • [6] Idiopathic inflammatory myopathies
    Crespo, MRG
    REVISTA CLINICA ESPANOLA, 2002, 202 (09): : 500 - +
  • [7] IDIOPATHIC INFLAMMATORY MYOPATHIES
    CRONIN, ME
    PLOTZ, PH
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1990, 16 (03) : 655 - 665
  • [8] Idiopathic inflammatory myopathies
    Amato, Antonio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [10] Idiopathic inflammatory myopathies
    Figarella-Branger, D
    Lacroix, C
    Coquet, M
    Gherardi, R
    Pellissier, JF
    ANNALES DE PATHOLOGIE, 2001, 21 (03) : 279 - 284